Institutional members access full text with Ovid®

Share this article on:

Research Highlights

Cecchini, Michael; Tsoulis, David J.; Velykoredko, Yuliya

Journal of the Dermatology Nurses' Association: November/December 2016 - Volume 8 - Issue 6 - p 400–402
doi: 10.1097/JDN.0000000000000269
DEPARTMENTS: Drugs in Dermatology

Michael Cecchini, MD, Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

David J. Tsoulis, MD, Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Yuliya Velykoredko, MD, Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

The authors declare no conflicts of interest.

Correspondence concerning this article should be addressed to Michael Cecchini, MD, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue Room M1-700, Toronto, ON, Canada M4N 3M5. E-mail: mcecchini@nosm.ca

Copyright © 2016 by the Dermatology Nurses' Association.